Company Quick10K Filing
Sunshine Biopharma
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 104 $0
10-Q 2019-11-13 Quarter: 2019-09-30
10-Q 2019-08-15 Quarter: 2019-06-30
10-Q 2019-05-20 Quarter: 2019-03-31
10-K 2019-04-12 Annual: 2018-12-31
S-1 2018-10-09 Public Filing
10-Q 2018-11-16 Quarter: 2018-09-30
10-Q 2018-08-17 Quarter: 2018-06-30
10-Q 2018-05-22 Quarter: 2018-03-31
10-K 2018-04-02 Annual: 2017-12-31
10-Q 2017-11-15 Quarter: 2017-09-30
10-Q 2017-08-11 Quarter: 2017-06-30
10-Q 2017-05-12 Quarter: 2017-03-31
10-K 2017-04-17 Annual: 2016-12-31
10-Q 2016-11-14 Quarter: 2016-09-30
10-Q 2016-08-16 Quarter: 2016-06-30
10-Q 2016-05-09 Quarter: 2016-03-31
10-K 2016-03-25 Annual: 2015-12-31
10-Q 2015-11-04 Quarter: 2015-09-30
10-Q 2015-08-06 Quarter: 2015-06-30
10-Q 2015-05-07 Quarter: 2015-03-31
10-K 2015-03-11 Annual: 2014-12-31
10-Q 2014-11-12 Quarter: 2014-09-30
10-Q 2014-08-12 Quarter: 2014-06-30
10-Q 2014-05-09 Quarter: 2014-03-31
10-K 2014-03-19 Annual: 2013-12-31
10-Q 2013-11-04 Quarter: 2013-09-30
10-Q 2013-08-06 Quarter: 2013-06-30
10-Q 2013-05-09 Quarter: 2013-03-31
10-K 2013-03-15 Annual: 2012-12-31
10-Q 2012-11-08 Quarter: 2012-09-30
10-Q 2012-08-08 Quarter: 2012-06-30
10-Q 2012-05-08 Quarter: 2012-03-31
10-K 2012-03-19 Annual: 2011-12-31
10-Q 2011-11-08 Quarter: 2011-09-30
10-Q 2011-08-09 Quarter: 2011-06-30
10-Q 2011-05-12 Quarter: 2011-03-31
10-K 2011-03-30 Annual: 2010-12-31
10-Q 2010-11-12 Quarter: 2010-09-30
10-Q 2010-08-04 Quarter: 2010-06-30
10-Q 2010-04-30 Quarter: 2010-03-31
8-K 2019-06-30 Leave Agreement, Exhibits
8-K 2019-03-12 Regulation FD, Other Events, Exhibits
8-K 2018-09-10 Enter Agreement, Regulation FD, Exhibits
8-K 2018-01-01 Enter Agreement, Regulation FD, Exhibits

Sunshine Biopharma Financials

SBFM Metrics, Comps, Filings

Annual | Quarterly

Business

The Company was originally incorporated under the name Mountain West Business Solutions, Inc. (“MWBS”) on August 31, 2006 in the State of Colorado. Effective October 15, 2009, MWBS acquired Sunshine Biopharma, Inc. in a transaction classified as a reverse acquisition. MWBS concurrently changed its name to Sunshine Biopharma, Inc. and Sunshine Biopharma, Inc. changed its name to Sunshine Etopo, Inc. In 2015, Sunshine Etopo, Inc. became inactive and was recently dissolved.

On July 25, 2014, the Company formed a Canadian wholly owned subsidiary, Sunshine Biopharma Canada Inc., for the purposes of offering generic prescription drugs and over-the-counter dietary supplements.

On January 1, 2018, the Company acquired Atlas Pharma Inc., a Health Canada certified Canadian company offering chemical analysis of pharmaceutical and other industrial samples.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
IGM Biosciences (IGMS)
ATIF Holdings (ATIF)
Rennova Health (RNVA) 0 3% -1.8 -143% 19,433 39,768 9,900 311 -27,876 -9,719 17,838
United States Short Oil Fund (DNO) 0 -0% 0.0 0 0 -600 0 -1,856 -1,856 -0
Rise Gold (RYES)
InCapta (INCT) 0 0% -0.2 -24,825% 8 1,331 3 0 -2,092 -1,709 268
Cerebain Biotech (CBBT) 0 -2.6 -7,425% 22 6,686 0 0 -1,601 -1,281 3,294
HyperSolar (HYSR) 0 0.4 2,642% 151 6,662 0 0 3,978 4,820 1,748
Daniels Corporate Advisory (DCAC) 0 24% 0.2 -127% 547 2,757 2,368 557 -694 -622 -129
Owl Rock Capital (ORCC)
Sunshine Biopharma (SBFM) 0 23% 0.0 -1,974% 109 926 372 85 -2,160 -1,984 -37
Kibush Capital (DLCR) 0 -59% -0.2 -220% 178 3,452 162 -96 -392 -382 88
GIFA (FRFS) 0 63% -0.9 43% 80 362 98 62 34 34 -30
AIM Exploration (AEXE) 0 0.0 -128% 832 2,337 0 0 -1,068 -1,009 -0
Global Boatworks (GBBT) 0 22% 0.0 -717% 79 2,004 750 166 -564 -577 -3
PetLife Pharmaceuticals (PTLF) 0 -0.1 -47,202% 8 1,981 0 0 -3,708 -3,708 205
Vilacto Bio (VIBI) 0 17% -0.0 -3,636% 538 3,960 5 1 -19,550 -19,519 17
89bio (ETNB)
ProGreen (PGUS) 0 0% -0.1 -176% 1,863 6,266 61 0 -3,277 -210 17
Yinghong Guangda Technology (UBLI) 0 24% 0.0 0 21 1,377 326 -1,329 -1,280 -0

Balance Sheet ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-06-302018-12-31
Cash6113331143515710836115
Accounts Receivable10895
Inventory
PP&E4660300269
Assets10613531143673642571,1701,147
Accounts Payable312435472819139191
Long-Term Debt0070800290
Liabilities364395311,2702748311,4461,202
Stockholders' Equity10370-8-388-597-210-573-276-56
Income Statement ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-06-302018-12-31
Revenue0000200447
Cost of Revenue391
Gross Profit56
R&D1432137327933013
SG&A6977071,9361,8607829938571,223
Tax0000000
Net Income-556-708-2,491-1,934-1,652-3,497-1,040-2,160
Cash Flow ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-06-302018-12-31
Cash Operating-297-393-564-539-868-314-544-513
Cash Investing000-624-3-84-14
Cash Financing1964654636511,399325671528